CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- 4 Grant or award Director acquired 3,150 shares (grant or award)
- 4 Grant or award Director acquired 3,150 shares (grant or award)
- 4 Grant or award Director acquired 3,150 shares (grant or award)
- 4 Open-market sale Director sold 16,000 shares at $35.11 ($561,694)
- 4 Grant or award Director acquired 3,150 shares (grant or award)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale Chief Operating Officer sold 6,185 shares at $35.00 ($216,492)
- 4 Open-market sale Director sold 60,000 shares at $35.57 ($2,134,278)
- 4 Open-market sale President & CEO sold 38,989 shares at $35.01 ($1,364,923)
- 4 Open-market sale Chief Financial Officer sold 6,185 shares at $35.00 ($216,481)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 3 of 33 · 652 filings